Bracco-Eisai

Bracco-Eisai is a joint venture between the Italian imaging specialist Bracco Imaging S.p.A. and the Japanese pharmaceutical company Eisai Co., Ltd. Established in 1990, the company focuses on the development, manufacture, and commercialization of diagnostic imaging agents within the Japanese market. Its product portfolio includes widely used contrast media for X-ray, CT, MRI, and ultrasound applications, such as Iomeron and ProHance. The company leverages Bracco's global leadership in contrast media and Eisai's extensive distribution network and regulatory expertise in Japan. Bracco-Eisai plays a critical role in the Japanese healthcare system by providing advanced diagnostic tools for oncology, cardiology, and neurology.